Beta 2 agonists and asthma.
Rees
J
J
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D000420:Albuterol / Q000031:analogs & derivatives / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001985:Bronchial Provocation Tests; D004983:Ethanolamines / Q000627:therapeutic use; D005280:Fenoterol / Q000627:therapeutic use; D000068759:Formoterol Fumarate; D006801:Humans; D000068299:Salmeterol Xinafoate
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D004983:Ethanolamines; D005280:Fenoterol; D000068299:Salmeterol Xinafoate; D000420:Albuterol; D000068759:Formoterol Fumarate